I will now go through the paper on a page by page basis outlining what I see as the major problems.
Page 2: in the first paragraph of the "Introduction" section, the authors state that the direct medical cost of stroke is increasing each year at an average rate of over 18%. These seems extraordinarily high and if it was to persist for a number of years then stroke costs would soon catch up with total medical expenditure in China! So, either this is a misprint, or the authors need to explain what is going on here.
Pages 3 &4: here the authors explain some of the institutional background to the hospital system in China. I think it would be helpful if they explained the distinction between Western and Chinese medicine earlier in this discussion.
The authors state that mean fee per patient is 33867 and median fee is 18577. This suggests that the distribution is highly skewed. Hence standard regressions analysis (as is carried out here), where the effect of covariates are evaluated at the mean, could be supplemented with quantile based regression analysis. This would evaluate the effect of covariates at the median (which may be more representative) and would also permit the analysis of effects for very expensive patients (say by evaluating the effect at the 90th percentile). This could tell whether the effects of covariates are different for the most expensive patients. I accept that the log transformation of the charges may go some way towards making the distribution more normal and hence bring closer the mean and median, but I still think that quantile regression should be explored.
Page 5: in the summary statistics the authors present median BI scores on admission and discharge (they are 25 and 50 respectively). Yet the median BI score between admission and discharge (which I understand to be the median change in BI score) is only 5. Maybe I am misinterpreting these figures but it seems quite confusing and would benefit from clarification. Thirdly, all of the covariates enter in a linear manner. Thus there is no scope for non-linear effects e.g. concave or convex or quadratic effects. For example, it seems worth entering age as a quadratic to allow for this possibility. The same may be true of BI score on admission. There is a separate related issue here whereby BI score is being treated as a cardinal variable, which strictly speaking should not be the case. It is possible that different sub-classes of the BI score (for different activities) might have different effects and it could be worth checking this out.
Finally, it appears that some categorical variables are being treated as though they are cardinal e.g. occupation, where there are four different categories. The correct procedure here is to choose one category as the omitted category (it doesn't matter which) and then treat the remain categories as 0/1 dummy variables. This is not what appears to have been done here.
In terms of the discussion which follows, I also have a number of comments. First, I think it would be useful if some interpretation of the coefficients could be provided, this would make it a lot easier to understand and appreciate the results of the analysis.
I also think much of the discussion could be improved and suggests that the authors do not fully understand their results or the analysis they carried out. For example, they list mean hospital charges in a number of other countries, such as the US, Greece and Turkey. These results are presented in US dollars. Have the conversions from local currency been carried out using market or PPP exchange rates? It is not immediately clear which is appropriate here, but since much of medical costs arises from non-traded labour, it at least seems worth looking at PPP adjusted exchange rates.
Also I am not sure how meaningful these comparisons actually are. These are countries at different stages of development with different local wage rates etc so comparisons are difficult. The last sentence on page 9 also does not make sense. For sure because of its huge population the costs of pretty much all diseases in an absolute sense will be large in China. But what matters is the cost as a fraction of some measure like GDP or total medical expenditure. Effectively, all the last sentence is saying is that China is a big country! Page 10: the discussion here could also be improved. The finding that Level 3 hospitals have higher charges relative to level 2 hospitals is discussed and amongst the reasons provided ar the differing rates of surgery and ventilator usage. But these factors have already been accounted for by their inclusion in the regression! That is the whole point of multivariate regressions analysis, that such observable confounding can be controlled for. This comment applies to other parts of the discussion also.
The discussion also states that the impact of a higher BI score in a Level 3 hospital is greater than in a Level 2 hospital. The results do not actually show that, but if interaction terms were included then it would be possible to explicitly examine this.
Again in the final paragraph on page 10, I did not find the crosscountry comparison of the breakdown of hospital charges between the different countries to be very helpful.
Relative prices can be expected to differ across countries so it would be surprising if such differences were not observed.
Page 11: there is a discussion of LOHS. Once again, the finding that longer stays lead to higher charges does not seem very interesting. It might be interesting to see what observable characteristics of patients etc lead to longer LOHS i.e. regression analysis with LOHS as the dependent rather than an independent variable. Finally, the authors should make some comment about the benefits of medical care. We are told about how charges/costs differ by certain observable characteristics, but it might also be the case that benefits are higher here too, in which case the higher costs might not be such a problem. One potential measure of benefits might be the change in BI score between admission and discharge.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Comment: nice work, the costs of treatment are increasing in value over the last years, you present a large cohort with sufficient data, yet a comparison to Europe and the US might be difficult due to the differences in demographic structure as well as population numbers. Reply: Thank you for the reviewer's comment. According to the reviewer's advice, I added some discussion to illustrate the difficulty of this comparison.
Reviewer: 2 Comment: The study contains a large amount of data which is well organized. The conclusions regarding length of stay, preexisting comorbidities and in hospital surgery being associated with higher costs is expected. What could have added to the data is separation of hemorrhagic stroke subtypes such as SAH, parenchymal hemorrhage etc. Within the limitations mentioned by the authors this is nonetheless useful data and can serve as a comparative marker with similar studies from other centers across the world. Reply: The reviewer's advice made sense. Because many of the subtypes of hemorrhagic stroke were unclear in our data, we were not able to classify accurately. If we can get more detailed data in the future, we will analyze further according to your advice.
Reviewer 3: 1) One of the key findings was that length of hospital stay was a highly significant predictor of total hospital charges. However, this seems to still include a large range of lengths of stay, especially since the median was 15 days, and IQR=9.1-23.0.What was the reasoning behind this exclusion criteria, and were they based on previous studies? Did the authors conduct any sensitivity analyses with a more limited range to see if this significantly impacted the results? Reply: The clinical path and grading system in China is imperfect, which is still so far from developed countries in Europe and America. Due to lack of system supervision, some patients can stay in hospitals for a long time (even for years) while maintaining their lives. The hospitalization costs in this case are not generic and have no analytical value. We took over 180 d as our exclusion criteria was not to reduce the skewed distribution of data, but to rule out the abnormal condition of being hospitalized for too long.
2) Could a brief description of these systems be provided, such as the rural cooperative medical service and state free medical care, and the types of patients who would qualify or use these systems?
Reply: According to the reviewer's advice, I supplemented a brief description of medical payment type in China in my discussion part.
3) Is it possible to also determine the actual cost of care for patients in the Beijing Public Health Information Center database? This could add an additional layer of information to examine variations (if any) between hospital charges and costs for the different types of hospitals. Reply: Thank you for the reviewer's advice. It's a pity that we couldn't get the actual cost of care for patients. 4) Please include the total number of hospitals in your study, including the number of Level 2 vs 3, and western vs traditional Chinese medicine hospitals. Reply: I have added the total number of hospitals in my results (page 4). Reviewer 4: 1) Page 2: In the first paragraph of the "Introduction" section, the direct medical cost of stroke is increasing each year at an average rate of over 18%. These seems extraordinarily high and if it was to persist for a number of years then stroke costs would soon catch up with total medical expenditure in China! Reply: The direct medical cost of stroke is increasing each year at an average 18.04% growth rate from 2003 to 2010 and the direct economic burden caused by stroke is up to 40 billion CNY every year. I revised this part in the article.
2) Pages 3 & 4: I think it would be helpful if they explained the distinction between Western and Chinese medicine earlier in this discussion. Reply: According to the reviewer's advice, I supplemented the distinction between Western and Chinese medicine earlier in my article (page 3).
3) Page 5: in the summary statistics the authors present median BI scores on admission and discharge (they are 25 and 50 respectively). Yet the median BI score between admission and discharge (which I understand to be the median change in BI score) is only 5. Maybe I am misinterpreting these figures but it seems quite confusing and would benefit from clarification. Reply: According to the reviewer's advice, I explained that the median BI score between admission and discharge was median change in BI score (page 3,5). Not all patients had higher BI scores on discharge than on admission. The median change in BI score was only 5. 4) Page 7: Does the p value here refer to the equality of the median value for all categories in table 5? If so, this should be made clear. If this is not the case and it only refers to certain bivariate comparisons, then it should be made clear which ones are involved. Reply: According to the reviewer's advice, I have made it clear that the p value refer to the equality of the median value for all categories (page 7). 5) Page 7: Second, I am not convinced as to how useful it is to present data on HLOS. Surely the relevant variable is HLOS per day. It does not seem to add much value to tell us that longer hospital stays involve higher charges, what seems to be of more interest is whether charges rise linearly or non-linearly with length of stay.
Reply: Since China has such a large population, medical resources and number of open beds in hospitals are relatively inadequate. In order to avoid unnecessary hospitalization and make full use of medical resources, the government has attached importance to HLOS and launched many policies to improve the rate of bed rotation. 6) Page 9: (table 6) First of all, the table should state what the dependent variable is (I assume it is the log of total hospital charges). Secondly, as I stated above, I think a more useful dependent variable would be hospital charges per day, rather than total. Reply: According to the reviewer's advice, I stated the dependent variable is the log of total hospital charges in the article. The clinical path and grading system in China is imperfect, which is different from developed countries in Europe and America. Due to lack of system supervision, many patients can stay in hospitals for a long time (even for years) while maintaining their lives. The hospitalization costs per day in these cases couldn't reflect the real hospital costs. Moreover, the proportion of beds and nursing expenses is very low in total hospital charges in China. Therefore, as HLOS increase, the total hospital charges increase mainly due to disease treatment needs instead of beds or nursing expenses. . 7) Page 9: (table 6)Thirdly, all of the covariates enter in a linear manner. Thus there is no scope for non-linear effects e.g. concave or convex or quadratic effects. For example, it seems worth entering age as a quadratic to allow for this possibility. The same may be true of BI score on admission. There is a separate related issue here whereby BI score is being treated as a cardinal variable, which strictly speaking should not be the case. It is possible that different sub-classes of the BI score (for different activities) might have different effects and it could be worth checking this out. Reply: According to the reviewer's advice, I turned age and BI score into categorical variables in multiple linear regression analysis. 8) Page 9: Finally, it appears that some categorical variables are being treated as though they are cardinal e.g. occupation, where there are four different categories. The correct procedure here is to choose one category as the omitted category (it doesn't matter which) and then treat the remain categories as 0/1 dummy variables. This is not what appears to have been done here. Reply: Thank you for your comments. I corrected this part in the article. 9) In terms of the discussion which follows, I also have a number of comments. First, I think it would be useful if some interpretation of the coefficients could be provided, this would make it a lot easier to understand and appreciate the results of the analysis. Reply: According to the reviewer's advice, I supplemented some interpretation of the coefficients in the article. 10) They list mean hospital charges in a number of other countries, such as the US, Greece and Turkey. These results are presented in US dollars. Have the conversions from local currency been carried out using market or PPP exchange rates? It is not immediately clear which is appropriate here, but since much of medical costs arises from non-traded labour, it at least seems worth looking at PPP adjusted exchange rates. Also I am not sure how meaningful these comparisons actually are. These are countries at different stages of development with different local wage rates etc so comparisons are difficult. Reply: The review's advice is very good. I revised and discussed in the article. 11) Page 10: the discussion here could also be improved. The finding that Level 3 hospitals have higher charges relative to level 2 hospitals is discussed and amongst the reasons provided ar the differing rates of surgery and ventilator usage. But these factors have already been accounted for by their inclusion in the regression! That is the whole point of multivariate regressions analysis, that such observable confounding can be controlled for. This comment applies to other parts of the discussion also. Reply: The reviewer's advice made sense. I revised this part of discussion.
12) The discussion also states that the impact of a higher BI score in a Level 3 hospital is greater than in a Level 2 hospital. The results do not actually show that, but if interaction terms were included then it would be possible to explicitly examine this. Reply: According to the reviewer's advice, I explained this in the article.(page 10) 13) Again in the final paragraph on page 10, I did not find the cross-country comparison of the breakdown of hospital charges between the different countries to be very helpful. Relative prices can be expected to differ across countries so it would be surprising if such differences were not observed. Reply: We wanted to make this comparison. However, we didn't find any breakdown of hemorrhagic stroke hospital charges in other countries. 14) Page 11: there is a discussion of LOHS. Once again, the finding that longer stays lead to higher charges does not seem very interesting. It might be interesting to see what observable characteristics of patients etc lead to longer LOHS i.e. regression analysis with LOHS as the dependent rather than an independent variable. Reply: Since China has such a large population, medical resources and number of open beds in hospitals are relatively inadequate. In order to avoid unnecessary hospitalization and make full use of medical resources, the government has launched many policies to improve the rate of bed rotation. As a result, it makes sense to study the direct relationship between LOHS and total hospital charges. According to the reviewer's advice, I also made an analysis to see what observable characteristics of patients etc lead to longer LOHS and added the results in the article. 15) Finally, the authors should make some comment about the benefits of medical care. We are told about how charges/costs differ by certain observable characteristics, but it might also be the case that benefits are higher here too, in which case the higher costs might not be such a problem. One potential measure of benefits might be the change in BI score between admission and discharge. Reply: According to the reviewer's advice, I added this part in the article.
